Reminder: You are viewing our sharing site. Content may differ from our live site.
Skip to main content

# Anti-androgens - Whole blood and components

## Essential information

Includes

  Bicalutamide (Casodex®), cyproterone acetate (Androcur®, Cyprostat®), dutasteride (Avodart®), finasteride (Propecia®, Proscar®), flutamide (Drogenil®).

Obligatory

  Must not donate if:

  1. Dutasteride (Avodart®) taken in the last 6 months.
  2. Finasteride (Propecia®, Proscar®) taken in the last 4 weeks.
  3. Bicalutamide (Casodex®), cyproterone acetate (Androcur®, Cyprostat®) or flutamide (Drogenil®) has been taken for a malignant condition.
Discretionary
  1. Donors taking cyproterone acetate for non-malignant conditions, if not affected by the Blood Safety entry, accept.
  2. Donors using topical anti-androgen treatments for alopecia, including male pattern baldness, accept.

## Supporting information

See if relevant
  - Acne
  - Blood safety
  - Hair removal
  - Malignancy
  - Prostate problems
Additional information

  Dutasteride and finasteride can cause abnormal development of the sexual organs of a male baby within the womb. As it is not possible to know if an individual donation may be transfused to a pregnant woman whose baby may be at risk, donations cannot be taken from people who may have one of these drugs in their blood. They remain in the blood even after treatment has stopped.

  Cyproterone acetate (particularly in the form of Androcur®) may be used to treat male hypersexuality. In such cases a sensitive exploration of any relevant issues dealt with by the Blood safety entry should be undertaken.

Reason for change:
  A discretion to accept donors using topical anti-androgens has been added.
Version details:

  WB-DSG Edition 203 Release 74 (26 November 2024)

BETA

We recently updated this website. Help us improve it – give your feedback (opens in new tab)